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The Inflammation–Fibrosis Link? A Jekyll and Hyde Role
for Blood Cells during Wound Repair
Brian M. Stramer1, Ryoichi Mori1 and Paul Martin1
The healing of a skin wound is a complex process involving many cell lineages. In adult tissues, repair is always
accompanied by a robust inflammatory response, which is necessary to counter the potential for infection at
any site where the skin barrier is breached. Unlike embryonic tissues that can repair perfectly without a
remnant scar at the wound site, adult tissue repair always leads to formation of a fibrotic scar where the wound
has healed. In recent years, it has become clear that the wound inflammatory response may be, at least in part,
responsible for fibrosis at sites of tissue repair. In this review, we consider the beneficial vs the detrimental
functions of inflammatory cells during the repair response and compare data from other tissues, the lung, and
liver, where fibrosis and its resolution may be related to a damage-triggered inflammatory response. We also
consider how it may be possible to molecularly disentangle the potentially good from the bad influences of
inflammatory cells during tissue repair and how fundamental studies in inflammatory cell biology may prove
the way forward for development of drug targets in this respect.
Journal of Investigative Dermatology (2007) 127, 1009–1017. doi:10.1038/sj.jid.5700811
Introduction
Recruitment of inflammatory cells and
the subsequent laying down of extracel-
lular matrix during wound repair is a
normal and healthy response to tissue
damage as cells in the vicinity of the
wound become activated and migrate to
fill the breach (Figure 1). These rapid and
robust reparative events have clearly
been selected for so that an animal can
survive in hostile environments. How-
ever, it seems, in part, that we are victims
of our evolutionary success, because the
general end point of repair is excessive
and poorly ordered matrix deposition
and fibrosis, which affects normal-tissue
architecture and ultimately can disable
proper functioning of tissues. For this
reason, there has been much investiga-
tion into the molecular events underlying
fibrosis after tissue insult and much of the
data, as described in this review, im-
plicate the infiltrating leukocyte – the
inflammatory response – as being the
causal agent.
Wherever adult skin is damaged,
there is a massive influx of leukocytes
in order to prevent infection. However,
along with their involvement in innate
immunity, leukocytes also release fac-
tors that influence the behavior of other
cells around them. Early in the last
century, it was observed that inflam-
matory cells secrete factors that stimu-
late fibroblast growth (Carrel, 1921),
and since then many other studies have
indicated that inflammation may be
beneficial to the repair process (Leibo-
vich and Ross, 1975; DiPietro et al.,
1998; Nagaoka et al., 2000). For
example, an early study of the messen-
ger RNAs expressed by activated
macrophages at a wound site indicated
transforming growth factor (TGF)a, pla-
telet-derived growth factor (PDGF), and
TGFb as growth factors that are deli-
vered by recruited macrophages (Rap-
polee et al., 1988), and each one of
these growth factors has been shown in
some way or other to be beneficial in
wound healing (Mustoe et al., 1987;
Hebda, 1988). We now know of many
more such factors released by one or
more of the infiltrating leukocytic
lineages and almost all of these factors
will possibly have some positive effect
on some aspect of repair, be it kerati-
nocyte motility, fibroblast proliferation
or contraction, or the wound angiogenic
response. However, in recent years
there has been increasing evidence to
suggest that, at least in some respects,
leukocytes can also be bad for repair
and may actually promote fibrosis.
Insight into the role of inflammation
during repair comes not only from
studies in skin but from other organ
systems as well. Fibrosis is certainly not
unique to repair of skin tissues. Every
organ of the body can mount a repair
response that generally results in a
fibrotic lesion. Lung fibrosis as a result
of chronic obstructive pulmonary dis-
ease and liver fibrosis because of
hepatitis infection are just two exam-
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ples. This review will discuss both the
positive and negative aspects of inflam-
mation as a constituent component of
the repair process drawing on parallels
from other organ models besides the
skin. Unfortunately, as with most scien-
tific questions, the answers turn out to
be more complex than we might
initially have hoped.
Correlative indicators of an inflamma-
tion–fibrosis link in skin repair
At early stages of embryonic develop-
ment when tissue repair is very rapid
and recapitulates embryo morphogen-
esis, there is no inflammatory response
because the inflammatory lineages have
yet to be born (Hopkinson-Woolley
et al., 1994). Even at limb bud stages
of organogenesis, when the first macro-
phages appear in loose connective
tissues there is still no major recruitment
of these cells to wounds (Hopkinson-
Woolley et al., 1994). Not until much
later in development, equivalent to the
later stages of organogenesis, do wounds
trigger a significant inflammatory re-
sponse in the fetus and this correlates
with the first stage in development when
tissue repair leads to a fibrotic scar at the
healed wound site. This correlative link
between inflammation and fibrosis, with
a coincident transition onset time for
both, has been observed in several
organisms from mouse to man; in
mouse, the developmental transition
stage appears to be about embryonic
days 15–16, beyond which stage con-
siderably more macrophages are drawn
to wounds and their activation state also
appears increased (Whitby and Fergu-
son, 1991; Hopkinson-Woolley et al.,
1994; Cowin et al., 1998). Studies in rat
and rabbit fetuses suggest similar corre-
lations for neutrophil recruitment (Dix-
on, 1960; Adzick et al., 1985), whereas
human fetal surgeons generally find that
their lesions only heal without scars in
operations performed before the onset of
the third trimester (Adzick and Longaker,
1992). Curiously, this transition need not
necessarily be during the in utero period,
and thus is not necessarily linked to a
sterile environment or exposure of tis-
sues to amniotic fluid, because studies in
marsupials that are born developmen-
tally immature reveal that they neither
raise an inflammatory response nor scar
at the wound site until 9 days in the
pouch (Armstrong and Ferguson, 1995).
It has been proposed that the key
difference between embryonic and
adult wounds that may explain why
the one scars and the other does not, is
the differing level of various ‘‘profibro-
tic’’ growth factors – in particular the
TGFbs – released into the wound
milieu. Certainly, it seems that TGFb1
levels are reduced and this growth
factor is more rapidly cleared in em-
bryonic wounds (Whitby and Ferguson,
1991; Martin et al., 1993) than during
adult tissue repair (Frank et al., 1996),
and experiments to knock down TGFb1
levels at the adult wound site in order
to more resemble those seen during
embryonic and fetal repair, appear to
dramatically reduce scar formation in
the healed wound (Shah et al., 1992,
1994, 1995). Although a large bolus of
TGFb1 is delivered to the wound by







Figure 1. Relative time course of inflammatory cell recruitment to sites of tissue damage. Graphs indicate the approximate time course of influx and dispersal
of neutrophils, macrophages, T lymphocytes, and mast cells in a typical murine wound response, superimposed on the three classically considered and
overlapping phases of tissue repair (inflammation, proliferation/migration, and maturation/remodeling). The insets show neutrophil and macrophage
immunohistochemistry at the wound site at times of peak numbers of these two cell types and mast cells revealed by toluidine blue histochemistry.
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release from degranulating platelets,
and there is also expression by wound
epidermal cells, it is clear that the
major, sustained source of this growth
factor at the wound site is from macro-
phages (Ashcroft et al., 1999; Martin
et al., 2003), which are recruited to the
site of damage in adult tissues but
largely absent in an embryonic wound.
In the adult organism – indeed from
the developmental transition point on-
wards – a leukocyte influx is an
inevitable and rapid response to skin
damage. Within hours of wounding,
neutrophils are attracted to the wound
site followed by monocytes, which
mature into macrophages as they in-
vade tissues, and finally lymphocytes
and mast cells. Most of the recruited
cells are drawn in from the blood,
although there is likely to be some
contribution from small numbers of
resident cells also, particularly mast
cells whose effects seem to be greatest
at a time before they transit in any
numbers from the vasculature (Egozi
et al., 2003). All of these cell types are
likely to play key and integrated roles
in preventing infection and may con-
tribute to the signals that coordinate the
various aspects of tissue repair. Aside
from the correlation that fibrosis at
wounds only commences at late em-
bryonic stages, after these leukocytic
lineages have been born and are
robustly recruited to sites of tissue
damage, there are other clues that
various components of the inflamma-
tory response might be in part respon-
sible for fibrosis at the wound site.
For example, several correlative
studies have indicated links between
numbers of T cells and Langerhans cells
in the skin, and the resulting formation
of hypertrophic or keloid scars (Placik
and Lewis, 1992; Castagnoli et al.,
1997; Niessen et al., 2004) and mast
cells has been implicated also because
of association between increased IgE
levels and frequency of allergic symp-
toms in patients with excessive scarring
(Smith et al., 1997; Gruber, 2003).
There is considerable anecdotal
clinical evidence indicating that elderly
patients suffer much less extensive
hypertrophic scarring than younger
individuals (A McGrouther, Manche-
ster, personal communication). At a
basic science level, this has only been
investigated in as much as the observa-
tion that transfusions of ‘‘young’’
macrophages can accelerate the repair
process in aged animals (Danon et al.,
1989), suggesting that the inflammatory
response becomes sluggish and less
effective with age; the fact that transfu-
sion of macrophages can alter the
healing rate and the quality of repair
hints that inflammatory cells are active
regulators of the final repair phenotype.
In a similar vein, it has long been
observed that the oral mucosa of the
mouth has very different healing abil-
ities to the skin; in particular, the mouth
is much less prone to scar formation,
and this correlates with its reduced
inflammatory profile (Szpaderska et al.,
2003), providing further correlative
support that a high-grade inflammatory
response may in part underlie the
fibrotic by-product of repair in the skin.
More than just a correlative link between
inflammation and scarring following skin
repair
Because of the complexity of the
inflammatory response it has not been
trivial to directly analyze the role(s) of
each of the inflammatory cell lineages
in the repair response and to test which
components may be responsible for
fibrosis and how their effects might be
modulated. There has been a long
history of attempts to specifically de-
plete these lineages from the process,
beginning with two classic studies using
antisera raised against either neutrophils
or macrophages to deplete these two
cell types in a guinea-pig wound model.
These experiments showed that, so long
as conditions were kept sterile, antisera
depletion of neutrophils seemed not to
disturb tissue repair (Simpson and Ross,
1971, 1972), but depletion of macro-
phages with antimacrophage sera and
steroids resulted in a failure of debride-
ment – the clearance of dead and
damaged cells, fibrin, and other debris
from the wound – and as a result,
seriously disturbed the healing process
(Leibovich and Ross, 1975).
In recent years, gene knockout tech-
nologies in mice have provided opportu-
nities for genetic depletion of the various
leukocytic lineages alone, or in combina-
tion, to test their function in a wound-
healing context. The PU.1 knockout
mouse is missing several leukocytic
lineages including mast cells, neutrophils,
and macrophages and yet these mice are
able to heal wounds with a rather similar
time course, if not a little faster, than their
wild-type sibs (Martin et al., 2003). Not
only is the repair process able to operate
efficiently in the absence of a normal
cellular inflammatory response, but also
these wounds, like those in embryos
where there is also no wound inflamma-
tory response, heal with noticeably re-
duced scarring (Martin et al., 2003).
There are several explanations why these
data do not square with the earlier
macrophage depletion studies; one pos-
sibility is that the steroid applications to
guinea-pig wounds were not only anti-
inflammatory but also knocked down the
immediate early transcriptional activities
at the wound site, and this was partially
responsible for the failed repair. But
another key difference is that the PU.1-
null mice are not only missing macro-
phages but also the neutrophils that are
responsible for much of the cell debris at
wounds that must be cleared by macro-
phages, both because they kill so many
host wound cells with their free radicals
targeted for killing microbes, but also
because once spent, they themselves die
and must be cleared. The studies of repair
in PU.1-null mice could only be per-
formed in neonatal animals because
these mice die within weeks of birth,
but rather similar observations were also
made in smad 3 knockout mice, which
survive beyond the neonatal period,
despite disruption to this key TGFb
signaling pathway (Ashcroft et al.,
1999). In these mice, incisional wounds
exhibited a reduced influx of monocytes
and neutrophils and an increased rate of
re-epithelialization. As a consequence of
the reduced numbers of monocytes, there
was a reduction in TGFb levels in the
granulation tissue and consequently less
fibronectin production indicating dimin-
ished fibrotic repair. Exogenous addition
of TGFb or wild-type monocytes to these
wounds restored levels of fibronectin
expression in the granulation tissue with-
out rescuing levels of host inflammatory
cells or reducing the rate of re-epithelia-
lization, suggesting that this effect on
fibrosis was directly dependent on leu-
kocyte signaling (Ashcroft et al., 1999).
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A reminder that inflammation is not all
bad for healing
From the simplest interpretation of
some of the leukocyte depletion studies
above it might be tempting to believe
that, aside from the stemming of
bacterial infection, the inflammatory
response has no useful role in the tissue
repair process. This makes some sense
because we know that tissues can
repair perfectly well without inflamma-
tion because they do so in the embryo
before the onset of a robust immune
system. However, tissues in the adult
are far more complex and may need
more of a kick-start to reactivate cell
and tissue migrations than their em-
bryonic counterparts, which are ac-
tively undergoing morphogenetic
migrations as part of their normal
developmental program. Indeed, there
is still much evidence that inflamma-
tion has an important part to play in
orchestrating adult tissue repair and
that a gross blockade of the inflamma-
tory response, even in the presence of
the best antibiotics, would not be a
useful clinical therapy. For example,
contrary to the PU.1 and smad 3
studies is an experiment in which the
key macrophage chemoattractant
macrophage inhibitory protein-1a is
neutralized, leading to a dramatically
reduced macrophage response and
associated retarded healing (DiPietro
et al., 1998). Intercellular adhesion
molecule-1 and L-selectin knockout
mice have a delay in wound repair
and granulation tissue formation also,
which is similarly associated with
reduced inflammation (Nagaoka et al.,
2000). There is even evidence from a
human genetic disease, leukocyte ad-
hesion deficiency, which results in a
failure in leukocyte recruitment to sites
of inflammation because of mutations
in the integrin B2 gene (leukocyte
adhesion deficiency type 1) or im-
paired levels of adhesive glycoproteins
(leukocyte adhesion deficiency type II)
(Kishimoto et al., 1987; Lubke et al.,
2001; Luhn et al., 2001). The result of
these diminished adhesive properties of
leukocytes in leukocyte adhesion defi-
ciency is reduced inflammatory cell
recruitment to wound sites and im-
paired healing (Anderson et al., 1985).
One of the most dramatic demonstra-
tions, outside of skin repair, that
inflammatory cells may supply key
repair and regenerative signals comes
from studies of the regenerating optic
nerve where, as with most central
nervous system-repair scenarios, there
is generally only a short period of
impotent sprouting upon lesion of the
nerve tracts. Recent studies have
shown that nerve regeneration is hu-
gely enhanced if the nerve lesion is
preceded by a small scratch to the
cornea; this causes a local recruitment
of macrophages which appears to
prime the neural regenerative response
by release of growth factors expressed
uniquely by activated macrophages
(Leon et al., 2000; Yin et al., 2003).
Studies in the lung disassociate
inflammation from a fibrotic response
and in some instances indicate that
inflammation may aid in resolving fibrosis
In the lung, many types of insult can
trigger a cascade of events leading to
pulmonary fibrosis, which can comple-
tely compromise airway function. De-
pending on the type of lesion, fibrotic
resolution may be possible if further
exposure to the damaging agent is
avoided. Unfortunately, there are many
instances for which the etiology is
unknown and the resulting syndrome
is clinically termed ‘‘idiopathic’’. These
cases are often progressive in nature
with a grim prognosis.
The animal model normally used to
examine progressive pulmonary fibro-
sis is bleomycin exposure in rodents.
Approximately 1 week after bleomycin
treatment, lungs become inflamed fol-
lowed by accumulation of extracellular
matrix as lungs become progressively
fibrotic (Raisfeld, 1979). Fibrotic repair
within lungs is characterized by the
same fibrotic markers as skin, such as
an accumulation of collagen and fibro-
nectin matrix, fibroblast proliferation,
and myofibroblast transformation, and
as a similar portfolio of growth factors
and cytokines are expressed at the
lesion site, it is possible that there will
be at least some parallels between the
fibrotic response in skin and lung.
There has been conflicting evidence
linking progressive pulmonary fibrosis
and inflammation within recent years.
Originally, it was observed that patients
with numerous types of chronic fibrotic
disorders have a persistent alveolitis,
which led to the hypothesis that persis-
tent inflammation might be the cause of
lung fibrosis (Weinberger et al., 1978).
Since this finding, many groups have
discovered chemokines and cytokines
upregulated within lungs of patients
with fibrotic lesions (Homma et al.,
1995; Kunkel et al., 1995; Smith et al.,
1995; Belperio et al., 2001; Reichen-
berger et al., 2001; Keane et al., 2002;
Krein et al., 2003), suggesting that
inflammation was inducing fibroblast
proliferation and extracellular matrix
production via paracrine interactions.
Support of a role for inflammation in
lung fibrosis has also come from animal
models. Intercellular adhesion mole-
cule-1 and L-selectin knockout mice
show decreased fibrotic repair in re-
sponse to bleomycin treatment and this
decrease in fibrosis is associated with
reduced numbers of inflammatory cells
(Hamaguchi et al., 2002).
However, recently several groups
have started to question the inflamma-
tion–fibrosis link, at least as it pertains
to idiopathic pulmonary fibrosis (Gaul-
die, 2002). It seems that inflammation
is not always a histopathologic feature
of fibrotic disorders such as idiopathic
pulmonary fibrosis, suggesting that
other mechanisms might trigger fibro-
blast activation. Indeed, the extent of
inflammation does not correlate with
idiopathic pulmonary fibrosis outcome
(Nicholson et al., 2002), and anti-
inflammatory therapies have had limi-
ted success in resolving this disease
(Rudd et al., 1981). Basic science
studies compliment these observations
from the clinic in that numerous groups
have been able to uncouple fibrotic
progression from inflammation in ex-
perimental animal models of lung
disease. Integrin avb6 knockout mice
exhibit an exaggerated inflammatory
response to bleomycin treatment and
yet appear to be protected from further
fibrotic development (Munger et al.,
1999). By contrast, mice knockouts of
the chemokine receptor, CCR2, show a
reduced level of inflammation without
a consequent reduction in fibrotic
markers (Belperio et al., 2001). These
findings have led to a search for other
events that may be controlling fibrotic
1012 Journal of Investigative Dermatology (2007), Volume 127
BM Stramer et al.
Role for Blood Cells During Wound Repair
progression, and there is some evi-
dence suggesting that epithelial/stromal
interactions may be a key point of
regulation. The epithelium is capable
of producing many of the profibrotic
cytokines delivered by inflammatory
cells such as TGFb and PDGF (Anto-
niades et al., 1990). Furthermore,
epithelial damage in the absence of a
blood supply, and thus a source of
leukocytes, is sufficient to induce fi-
brotic repair (Adamson et al., 1988),
suggesting that sustained epithelial
damage or a deficiency in re-epithelia-
lization may be a driving force that
underlies fibrotic progression.
To further confound the inflamma-
tion–fibrosis hypothesis, recent evidence
suggests that some inflam-
matory cell products, in particular those
expressed by lymphocytes, may actually
be beneficial and prevent fibrotic devel-
opment in the lung. Jiang et al. (2004)
showed that mice deficient in CXC
chemokine receptor 3 (CXCR3) exhibit
increased fibrosis without an increase in
inflammation. These mice appear to
recruit fewer lymphocytes and natural
killer cells after bleomycin treatment
and without these inflammatory cells
there are reduced levels of IFN-g, which
has been shown to inhibit the extent of
pulmonary fibrosis after injury (Hyde
et al., 1988). Rescuing IFN-g levels,
directly or indirectly – by encouraging
lymphocyte recruitment – can restore
the repair response in these mice. So
here is an instance where inflammatory
cells, rather than being profibrotic
agents are clearly supplying antifibrotic
cytokines. Other indicators of this en-
dogenous antifibrotic pathway include
the observation that a number of che-
mokines including CXCL10, which is a
ligand for CXCR3, are able to exert an
antifibrotic role during lung repair
(Keane et al., 1999).
In the liver, macrophages can both
exacerbate a fibrotic response and also
aid in its resolution
Whether because of hepatitis infection
or chronic alcohol exposure, liver
fibrosis contains elements of a wound
response common to both skin and
lung. Activation of the hepatic stellate
cell, the fibroblast population of the
liver, leads to typical fibrotic markers
such as extracellular matrix accumula-
tion and myofibroblast transformation.
Just as with the other tissues discussed
here, there has been much investiga-
tion into the molecular mechanisms
leading to fibroblast activation, and not
surprisingly many have shown that
inflammation precedes the develop-
ment of extracellular matrix accumula-
tion and fibrotic progression (Friedman,
2003).
The Kupfer cells of the liver are the
resident macrophage population hy-
pothesized to stimulate hepatic stellate
cell activation. Reduction of Kupfer cell
numbers has been shown to diminish
hepatic fibrosis in response to carbon
tetrachloride poisoning (Titos et al.,
2003). Neutrophil infiltration also seems
key to fibrosis in the liver as knockdown
of IL-10, an anti-inflammatory cytokine,
results in a greater neutrophil influx and
an increase in liver fibrosis in response
to carbon tetrachloride (CCl4) treatment
(Louis et al., 1998). Furthering this link,
a pilot study examining IL-10 treatment
of hepatitis C patients showed a reduc-
tion in local inflammation and a con-
sequent decrease in fibrosis (Nelson
et al., 2000). Similarly, non-steroidal
anti-inflammatory drugs, in particular
drugs that inhibit Cox-2, have been
shown to aid in preventing the devel-
opment of liver fibrosis in animal
models (Endoh et al., 1996; Planaguma
et al., 2005).
However, a recent study in the liver
has added a twist to what we should
now consider to be the potential
repertoire of macrophage functions in
tissue repair and fibrosis (Duffield et al.,
2005). By transgenic expression of the
human diphtheria toxin receptor speci-
fically under the control of a murine
macrophage promoter, only these cells
become susceptible to diphtheria toxin
killing, as the equivalent murine re-
ceptor is several thousands fold less
sensitive to the toxin. Using this strat-
egy, it now becomes possible to
deplete macrophages at any particular
phase of the repair and regenera-
tion phase. Strikingly, depletion of
macrophages during progression of
liver fibrosis after CCL4 treatment yields
completely different results to deple-
tion during the standard recovery
phase. Removing macrophages during
progression had an antifibrotic effect,
whereas depletion during the recovery
phase led to sustained matrix accumu-
lation. Precisely how macrophages
mediate the development of fibrosis
during fibrotic progression in the liver
is unclear but it is likely to involve
paracrine interactions that activate he-
patic stellate cells, in ways that are
similar to macrophages signaling to
fibroblasts in a skin wound. It is also
unclear how macrophages are able to
aid resolution of the fibrotic process in
the liver. Potentially, their function is to
direct dispersal of activated hepatic
stellate cells and/or to degrade accu-
mulated matrix by proteolytic diges-
tion. This study raises several
interesting possibilities. It could be that
individual macrophages in the liver are
able to both trigger a fibrotic response
and subsequently to clear it away, or
perhaps there is more than one kind of
macrophage involved in these two
phases of the repair process. We do
not know yet whether macrophages
that are involved in the initiation of the
fibrotic response are the same cells
involved in resolution or whether other
bone marrow-derived macrophages are
specifically recruited for fibrotic clear-
ance?
Are there lessons from lung and liver that
might be extrapolated to skin repair?
The studies described above are both
confusing and encouraging for those
who might wish to extrapolate findings
from lung and liver repair to guide our
understanding of how skin heals. Stu-
dies in the lung suggest the existence
of antifibrotic signaling regimes via
chemokines including IFN-g. The po-
tential for such an antifibrotic pathway
has not been characterized in studies of
skin healing. However, the indicators
are that if there is a role for the
lymphocyte in skin repair, unlike in
the lung, it may be only as a profibrotic
agent. For example, the fibrotic dis-
ease, systemic sclerosis is associated
with autoimmunity because of autoan-
tibody production by B lymphocytes
(Bona and Rothfield, 1994) and in the
tight skin mouse model of systemic
sclerosis, either CD19 removal or knock-
down of IL-4 expression abrogates
this autoimmunity and significantly
www.jidonline.org 1013
BM Stramer et al.
Role for Blood Cells During Wound Repair
decreases development of skin fibrosis
(Sato et al., 2000; McGaha et al.,
2001).
What is very clear from the lung
studies is that chronic fibrotic lesions are
not necessarily linked to an exaggerated
or persistent inflammatory response and
may rather be due to epithelial–mesench-
ymal cell cross-talk at the wound site.
Of course there are differences in scale
because of the relatively thin layers of
connective tissue adjacent to lung epithe-
lium versus the thicker granulation tissue
of a skin wound, but perhaps inflamma-
tion-independent signals between these
tissues are profibrotic on some occasions
in skin repair also. We are well aware of
signals from dermal fibroblasts, such as
keratinocide growth factor, that instruct
the wound epidermis in its mitogenic and
motogenic repair behaviors (Finch et al.,
1989; Beer et al., 2000), but it may be
that we should also look for epithelial–-
mesenchymal-amplifying mechanisms in
the opposite direction that might underlie
some aspects of the scarring response
during skin repair; several studies show
growth factors, including TGFbs and
PDGF, expressed by wound epidermal
cells (Antoniades et al., 1991; Frank et al.,
1996) and indeed there are paradigms
for exquisite epithelial–mesenchymal sig-
naling crosstalk during developmental
stages when the appendages of the skin
are being laid down and the epithelium
is directing local mesenchymal conden-
sations (Bard, 1990).
The liver, with its striking capacity
for tissue regeneration, may be unusual
and therefore misleading with regard to
the generation and resolution of fibrotic
tissue in other organs, or it may be
revealing of what might be possible in
the skin by activating the appropriate
signals or overcoming the appropriate
blocks. What is clear is that inflamma-
tory cells in the liver are not only
responsible for generation of scar but
also have the capacity to resolve these
lesions. Currently, the evidence would
suggest that macrophages recruited to
skin wounds have only a limited
capacity, if any at all, for resolving the
wound scar, but we do not yet know
whether this is the fault of the macro-
phages, with Kupfer cells in some way
endowed with fibrosis-clearing
machinery not expressed by those cells
in skin, or whether the fibrosis resolu-
tion is more a feature of the host
connective tissue of liver parenchyma.
Clearly, a major goal will be to under-
stand these differences so we can
harness the fibrosis resolution capacity
of the liver and transfer it to other
tissues including the skin.
Blood-borne cells may also contribute to
the wound fibroblast population
To add to the complexity of the role of
leukocytes in tissue repair, we now have
to consider the possible role of fibrocytes
which appear to be a sub-population of
circulating leukocyte expressing both
hematopoetic markers such as CD34 as
well as collagen genes, suggesting these
cells are also ‘‘fibroblast’’ like (Quan
et al., 2004). Aside from expressing
matrix proteins, these cells secrete nu-
merous cytokines such as PDGF and
TGFb and so are clearly capable of
influencing resident fibroblast popula-
tions at the wound site, as well as further
amplifying the inflammatory process. It
seems that these chimaeric cells are able
to both present antigen, as an inflamma-
tory cell can, and to differentiate into
myofibrobalsts, just like a host wound
fibroblast (Abe et al., 2001). As tissue
repair progresses, there is circumstantial
evidence that fibrocytes mature into
tissue fibroblasts as indicated by the loss
of CD34, concomitant with an increase
in collagen expression (Aiba and Taga-
mi, 1997). Several studies have sug-
gested that these cells play a pivotal role
in a variety of fibrotic conditions, such as
scleroderma (Aiba et al., 1994), nephro-
genic fibrosing dermopathy (Cowper
and Bucala, 2003), and bronchial asth-
ma (Schmidt et al., 2003). The discovery
of the fibrocyte adds a new player to
consider in our understanding of repair
and its pathological consequences. Not
only are inflammatory cells controlling
the repair process by paracrine interac-
tions with local fibroblast populations,
but circulating cells may be differentiat-
ing into those fibroblast populations as
well.
How might we best modulate the wound
inflammatory response to make skin
wounds heal better?
Given our current understanding of the
link between inflammation and skin
repair, it makes good sense to cau-
tiously begin considering ways in
which we might dampen down the
inflammatory response in various ways
in order to improve the final quality of
healing. At a fundamental level, this
could be done at several key moments
in the inflammatory process (Figure 2):
leukocytes could be blocked in the
various steps leading to their transmi-
gration from the blood stream through
the vessel wall, or their migration from
vessel to wound could be blocked, or
their activation state could be modu-
lated so they no longer deliver their
‘‘fibrotic’’ message to host wound
fibroblasts, or the responding fibro-
blasts could be blocked in their re-
sponse to this fibrosis signal. To design
therapies that might target any of these
steps, it is clearly key to understand the
genetic basis of each step, and to a first
approximation, we do now have a fair
list of the genetic players in diapedesis
and the same, at least, for some aspects
of leukocyte migration. For example,
we know that selectins and integrins
are key for initial tethering and firmer
adhesion of leukocytes to the activated
endothelial linings of vessels and that
platelet–endothelial cell adhesion mo-
lecule is necessary for diapedesis and
for breaking through the underlying
basal lamina of the vessel wall into
the extravascular space (Muller, 2002).
We know that Rho family small gua-
nosine triphosphatase switches are
necessary for polarized crawling of
inflammatory cells toward the wound
cues (Stramer et al., 2005), but we do
not yet know precisely which cues are
responsible for drawing each of the
leukocytic lineages toward an in vivo
wound. A full characterization of the
transmembrane receptors expressed by
each lineage might give the best hope
of designing lineage-specific blockers
for this migrations step.
Having reached the wound site,
inflammatory cell activation state may
be crucial in determining to what
extent these cells deliver fibrotic signals
to the wound fibroblasts, but currently
little is known about what precisely
leads to activation of the various
leukocytic lineages in an in vivo
wound situation. There is a growing
body of evidence that TGFb1 and its
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downstream effector, connective tissue
growth factor, might be partially re-
sponsible for inflammation-mediated
fibrosis at skin wounds (Shah et al.,
1992; Daniels et al., 2003), but there
are likely to be other profibrotic factors
released by the various leukocytic
lineages at the wound site, and indeed
the studies from lung suggest we should
be hunting for antifibrotic factors also.
In this regard, there is some evidence
that TGFb3 may function in this way
and counter the profibrotic effects of
TGFb1 in skin wounds; if TGFb3 is
applied to incisional wounds in rat
skin, then scarring is reduced in a
manner similar to that seen after TGFb1
knockdown with neutralizing anti-
bodies (Shah et al., 1995).
Downstream of the profibrotic sig-
nals delivered by leukocytes, we need
to identify the ‘‘fibrosis’’ signature of
genes expressed by fibroblasts as a
consequence of these signals. Such a
signature can be gathered by subtrac-
tive array studies of wound tissues
healing in the presence or absence of
an inflammatory response (Cooper
et al., 2005). Perhaps it is at this level
where comparisons of skin, lung, and
liver repair and fibrosis would become
most powerful, as gene overlaps may
represent the ‘‘generic’’ fibrotic re-
sponse genes and differences may
explain why one tissue can resolve
fibrosis and another cannot.
One key lesson from the diphtheria
toxin liver macrophage depletion stu-
dies (Duffield et al., 2005) and from
TGFb1 knockdown studies in skin
wounds, where late delivery of anti-
bodies fails to block scarring (Shah
et al., 1994), is that the timing of any
intervention is crucial, in part, because
leukocytes are doing different things at
different times in the repair process
and, in part, because the inflammatory
response is somewhat self-amplifying
so that once initiated it is difficult to
dampen down. It is now becoming
clear that there are naturally occurring
resolving mechanisms that might be
harnessed better in order to subtly
control the inflammatory response.
The lipoxins, resolvins, and protectins
are newly identified lipid mediators
which are rapidly synthesized at sites
of inflammation and appear to ‘‘self-
limit’’ inflammation by shutting down
the diapedesis step and triggering
neutrophil apoptosis (Serhan and Savill,
2005). Other potential tools for con-
trolling, when inflammatory cells
‘‘go home’’, are the slits and other
molecules that regulate growth cone
guidance in the developing nervous
system and appear also to be repulsive
to several of the leukocyte lineages
(Wong et al., 2002).
Finally, we clearly need to learn far
more about the role of fibrocytes in the
skin-repair process and whether they
are generally ‘‘regenerative’’ or ‘‘pro-
fibrotic’’ at the wound site. Either way,
we need to learn how to modulate their
numbers at the wound site in the ways
we have been discussing for the more
traditional leukocytic lineages above.
Conclusion
Clearly, the link between inflammation
and fibrosis is not straightforward.
However, it is clear that inflammatory
cells do seem to direct fibrosis forma-
tion, at least to some extent, in all
tissues so far examined. Some leuko-
cytic lineages may also deliver anti-
fibrotic signals, and in the liver, at least,
macrophages have the capacity to
resolve the fibrotic lesions that they
were in part responsible for forming.
While considering ways to dampen the
inflammatory response by blocking
various of the migratory steps during
leukocyte recruitment, or preventing
the molecular conversation between
leukocyte and fibroblast that leads to
fibrosis, we must not discard opportu-
nities for harnessing these endogenous
antifibrotic mechanisms that already
function well in some tissues but might
be naturally silent, or less robust, in the
healing of skin wounds. We hope that
by continually comparing how the
various different organ systems undergo
tissue repair, we will gain useful leads
in our understanding of both generic
and tissue-specific repair machinery
that will guide us to know how skin
might be forced to heal better.
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